Hepatitis Screening and Treatment Campaign in Malaysia-Validation of Low-cost Point of Care Screening Tests and Nucleic Acid Tests for Hepatitis B and C.

Journal: Euroasian journal of hepato-gastroenterology
Published Date: Feb 1, 2019

Abstract

BACKGROUND: Two major challenges in implementing budget-constrained Hepatitis screening and treatment campaign in Malaysia are the availability of low-cost point of care tests (POCT) and nucleic acid tests (NAT) for hepatitis C virus ribonucleic acid (HCV RNA) and hepatitis B virus dioxyribo nucleic acid (HBV DNA). We evaluated the performance of these tests in this study.

Authors

  • Muhammad Radzi Ah
    Hospital Sultanah Bahiyah, Alor Setar, Malaysia.
  • Soek S Tan
    Hospital Selayang, Selangor, Malaysia.
  • Rosmawati Mohamed
    University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  • Fauziah Jaya
    Gastroenterology and Hepatology, Hospital Raja Permaisuri Bainun, Ipoh Perak, Malaysia.
  • Senamjit K
    Hospital, Raja Permaisuri Bainun Ipoh, Perak, Malaysia.
  • Azlida C Aun
    Gastroenterology, Hospital Tengku, Ampuan Afzan, Kuantan, Pahang, Malaysia.
  • Ghazali A Kutty
    Nephrologist, Hospital Kuala Lumpur, Malaysia.
  • Hin S Wong
    Hospital Selayang, Selangor, Malaysia.
  • Rafidah Abdullah
    Hospital Temerloh, Pahang, Malaysia.
  • Mohd R Seman
    Hospital Tengku, Ampuan Afzan, Kuantan, Pahang, Malaysia.
  • Mamun Al Mahtab
    Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
  • Zaki Morad
    National Kidney Foundation, Kuala Lumpur, Malaysia.
  • Teck-Onn Lim
    Hepatitis Free Pahang Society, Pahang Malaysia.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals